Literature DB >> 25104438

Investigation of localized delivery of diclofenac sodium from poly(D,L-lactic acid-co-glycolic acid)/poly(ethylene glycol) scaffolds using an in vitro osteoblast inflammation model.

Laura E Sidney1, Thomas R J Heathman, Emily R Britchford, Arif Abed, Cheryl V Rahman, Lee D K Buttery.   

Abstract

Nonunion fractures and large bone defects are significant targets for osteochondral tissue engineering strategies. A major hurdle in the use of these therapies is the foreign body response of the host. Herein, we report the development of a bone tissue engineering scaffold with the ability to release anti-inflammatory drugs, in the hope of evading this response. Porous, sintered scaffolds composed of poly(D,L-lactic acid-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) were prepared with and without the anti-inflammatory drug diclofenac sodium. Analysis of drug release over time demonstrated a profile suitable for the treatment of acute inflammation with ∼80% of drug released over the first 4 days and a subsequent release of around 0.2% per day. Effect of drug release was monitored using an in vitro osteoblast inflammation model, comprised of mouse primary calvarial osteoblasts stimulated with proinflammatory cytokines interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ). Levels of inflammation were monitored by cell viability and cellular production of nitric oxide (NO) and prostaglandin E2 (PGE2). The osteoblast inflammation model revealed that proinflammatory cytokine addition to the medium reduced cell viability to 33%, but the release of diclofenac sodium from scaffolds inhibited this effect with a final cell viability of ∼70%. However, releasing diclofenac sodium at high concentrations had a toxic effect on the cells. Proinflammatory cytokine addition led to increased NO and PGE2 production; diclofenac-sodium-releasing scaffolds inhibited NO release by ∼64% and PGE2 production by ∼52%, when the scaffold was loaded with the optimal concentration of drug. These observations demonstrate the potential use of PLGA/PEG scaffolds for localized delivery of anti-inflammatory drugs in bone tissue engineering applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25104438      PMCID: PMC4293093          DOI: 10.1089/ten.TEA.2014.0100

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  53 in total

1.  Development of an Ibuprofen-releasing biodegradable PLA/PGA electrospun scaffold for tissue regeneration.

Authors:  Irene Cantón; Robert Mckean; Mirren Charnley; Keith A Blackwood; Calogero Fiorica; Anthony J Ryan; Sheila MacNeil
Journal:  Biotechnol Bioeng       Date:  2010-02-01       Impact factor: 4.530

2.  Analysis of sintered polymer scaffolds using concomitant synchrotron computed tomography and in situ mechanical testing.

Authors:  A Dhillon; P Schneider; G Kuhn; Y Reinwald; L J White; A Levchuk; F R A J Rose; R Müller; K M Shakesheff; C V Rahman
Journal:  J Mater Sci Mater Med       Date:  2011-09-10       Impact factor: 3.896

Review 3.  The biology of fracture healing in long bones.

Authors:  B McKibbin
Journal:  J Bone Joint Surg Br       Date:  1978-05

4.  The non-steroidal anti-inflammatory drug diclofenac reduces appearance of osteoblasts in bone defect healing in rats.

Authors:  G D Krischak; P Augat; R Blakytny; L Claes; L Kinzl; A Beck
Journal:  Arch Orthop Trauma Surg       Date:  2007-01-24       Impact factor: 3.067

5.  Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Authors:  T Kon; T J Cho; T Aizawa; M Yamazaki; N Nooh; D Graves; L C Gerstenfeld; T A Einhorn
Journal:  J Bone Miner Res       Date:  2001-06       Impact factor: 6.741

6.  Rat liver slices as a tool to study LPS-induced inflammatory response in the liver.

Authors:  P Olinga; M T Merema; M H de Jager; F Derks; B N Melgert; H Moshage; M J Slooff; D K Meijer; K Poelstra; G M Groothuis
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

7.  Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro.

Authors:  F J Hughes; L D Buttery; M V Hukkanen; A O'Donnell; J Maclouf; J M Polak
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

8.  Cyclo-oxygenase 2 function is essential for bone fracture healing.

Authors:  Ann Marie Simon; Michaele Beth Manigrasso; J Patrick O'Connor
Journal:  J Bone Miner Res       Date:  2002-06       Impact factor: 6.741

Review 9.  Modulation of the inflammatory response for enhanced bone tissue regeneration.

Authors:  Paschalia M Mountziaris; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2008-06       Impact factor: 6.389

10.  Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model.

Authors:  Yi-Rang Na; Yi-Na Yoon; Da-In Son; Seung-Hyeok Seok
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more
  8 in total

1.  Localized and targeted delivery of NSAIDs for treatment of inflammation: A review.

Authors:  Rebecca M Haley; Horst A von Recum
Journal:  Exp Biol Med (Maywood)       Date:  2018-07-12

2.  Pyrrole and Fused Pyrrole Compounds with Bioactivity against Inflammatory Mediators.

Authors:  Samar Said Fatahala; Sherifa Hasabelnaby; Ayman Goudah; Ghada I Mahmoud; Rania Helmy Abd-El Hameed
Journal:  Molecules       Date:  2017-03-17       Impact factor: 4.411

3.  Poly(vinyl alcohol boric acid)-Diclofenac Sodium Salt Drug Delivery Systems: Experimental and Theoretical Studies.

Authors:  Daniela Ailincai; Alexandra Maria Dorobanțu; Bogdan Dima; Ștefan Andrei Irimiciuc; Cristian Lupașcu; Maricel Agop; Orzan Olguta
Journal:  J Immunol Res       Date:  2020-05-31       Impact factor: 4.818

4.  Physicochemical and Biological Characterisation of Diclofenac Oligomeric Poly(3-hydroxyoctanoate) Hybrids as β-TCP Ceramics Modifiers for Bone Tissue Regeneration.

Authors:  Katarzyna Haraźna; Ewelina Cichoń; Szymon Skibiński; Tomasz Witko; Daria Solarz; Iwona Kwiecień; Elena Marcello; Małgorzata Zimowska; Robert Socha; Ewa Szefer; Aneta Zima; Ipsita Roy; Konstantinos N Raftopoulos; Krzysztof Pielichowski; Małgorzata Witko; Maciej Guzik
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

5.  The Effect of Diclofenac Sodium-Loaded PLGA Rods on Bone Healing and Inflammation: A Histological and Histomorphometric Study in the Femur of Rats.

Authors:  Karoline M Reich; Petrus Viitanen; Ehsanul Hoque Apu; Stefan Tangl; Nureddin Ashammakhi
Journal:  Micromachines (Basel)       Date:  2020-12-12       Impact factor: 2.891

Review 6.  Polyhydroxyalkanoates, bacterially synthesized polymers, as a source of chemical compounds for the synthesis of advanced materials and bioactive molecules.

Authors:  Maciej W Guzik
Journal:  Appl Microbiol Biotechnol       Date:  2021-09-18       Impact factor: 4.813

7.  Biomimetic Citrate-Coated Luminescent Apatite Nanoplatforms for Diclofenac Delivery in Inflammatory Environments.

Authors:  Sandra Maria Cano Plá; Annarita D'Urso; Jorge Fernando Fernández-Sánchez; Donato Colangelo; Duane Choquesillo-Lazarte; Riccardo Ferracini; Michela Bosetti; Maria Prat; Jaime Gómez-Morales
Journal:  Nanomaterials (Basel)       Date:  2022-02-06       Impact factor: 5.076

8.  Study on the Effect of PDA-PLGA Scaffold Loaded With Islet Cells for Skeletal Muscle Transplantation in the Treatment of Diabetes.

Authors:  Meishuang Zhang; Hongwei Du; Yueqi Guan; Jingyue Liu; Sushan Wang; Haoran Li; Wenyou Zhang; Hao Han; Ming Zhang; Li Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.